Dejian Zhou

Prof. Dr. Dejian Zhou

School of Chemistry and Astbury Centre for Structural Molecualr Biology, University of Leeds, Leeds LS2 9JT, UK
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2009 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
ECEnjun Cheng
Enjun Cheng
YXYongzheng Xing
Yongzheng Xing
PCPing Chen
Ping Chen
YYYang Yang
Yang Yang
YSYawei Sun
Yawei Sun
LDLiu Dongsheng
Liu Dongsheng

21 January 2006 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
DLDongsheng Liu
Dongsheng Liu
ABAndreas Bruckbauer
Andreas Bruckbauer
CAChris Abell
Chris Abell
SBShankar Balasubramanian
Shankar Balasubramanian
Dae Joon KangDae Joon Kang
Dae Joon Kang
DZDejian Zhou
Dejian Zhou

12 October 2008 in Nature Nanotechnology
Verified
Journal Article
Closed access
JNJoseph Wafula Ndieyira
Joseph Wafula Ndieyira
MWMoyu Watari
Moyu Watari
ABAlejandra Donoso Barrera
Alejandra Donoso Barrera
DZDejian Zhou
Dejian Zhou
MVManuel Vögtli
Manuel Vögtli
RMRachel McKendry
Rachel McKendry

1 July 2002 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ABAndreas Bruckbauer
Andreas Bruckbauer
LYLiming Ying
Liming Ying
ARAlison M. Rothery
Alison M. Rothery
DZDejian Zhou
Dejian Zhou
ASAndrew I. Shevchuk
Andrew I. Shevchuk
DKDavid Klenerman
David Klenerman

6 September 2005 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
DZDejian Zhou
Dejian Zhou
JPJoe D. Piper
Joe D. Piper
CAChris Abell
Chris Abell
DKDavid Klenerman
David Klenerman
Dae Joon KangDae Joon Kang
Dae Joon Kang
LYLiming Ying
Liming Ying
We show that direct coupling of a dye-labelled DNA (acceptor) to a quantum dot (QD) donor significantly reduces the donor–acceptor distance and improves the FRET efficiency: a highly efficient FRET (∼88%) at a low acceptor-to-donor ratio of 2 has been achieved at the single-molecule level.

1 June 2016 in Journal of Controlled Release
Verified
Journal Article
Open access
WZWenjun Zhang
Wenjun Zhang
FWFeihu Wang
Feihu Wang
YWYun Wang
Yun Wang
JWJining Wang
Jining Wang
YYYanna Yu
Yanna Yu
DZDejian Zhou
Dejian Zhou
A thiolated pH-responsive DNA conjugated gold nanorod (GNR) was developed as a multifunctional nanocarrier for targeted, pH-and near infrared (NIR) radiation dual-stimuli triggered drug delivery. It was further passivated by a thiolated poly(ethylene glycol)-biotin to improve its cancer targeting ability by specific binding to cancer cell over-expressed biotin receptors. Doxorubicin (DOX), a widely used clinical anticancer drug, was conveniently loaded into nanocarrier by intercalating inside the double-stranded pH-responsive DNAs on the GNR surface to complete the construction of the multifunctional nanomedicine. The nanomedicine can rapidly and effectively release its DOX payload triggered by an acidic pH environment (pH~5) and/or applying an 808nm NIR laser radiation. Compared to free DOX, the biotin-modified nanomedicine displayed greatly increased cell uptake and significantly reduced drug efflux by model multidrug resistant (MDR) breast cancer cell lines (MCF-7/ADR). The application of NIR radiation further increased the DOX release and facilitated its nuclear accumulation. As a result, this new DNA-GNR based multifunctional nanomedicine exerted greatly increased potency (~67 fold) against the MDR cancer cells over free DOX.